Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments.

These results suggest that fragments of surgical specimens from brain tumor patients are unsuitable for implementation of brain tumor PDX models, and instead recommend other in vivo testing platforms for brain tumors, such as cell-based brain tumor models.